FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 111 filers reported holding FULCRUM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $27,064 | -73.3% | 9,496 | -31.8% | 0.00% | – |
| Q4 2022 | $101,374 | -2.5% | 13,925 | +8.3% | 0.00% | – |
| Q3 2022 | $104,000 | +22.4% | 12,859 | -25.8% | 0.00% | – |
| Q2 2022 | $85,000 | -77.9% | 17,319 | +6.1% | 0.00% | – |
| Q1 2022 | $385,000 | +19.2% | 16,328 | -10.6% | 0.00% | – |
| Q4 2021 | $323,000 | +438.3% | 18,258 | +757.6% | 0.00% | – |
| Q3 2021 | $60,000 | +233.3% | 2,129 | +20.6% | 0.00% | – |
| Q2 2021 | $18,000 | -18.2% | 1,765 | -7.5% | 0.00% | – |
| Q1 2021 | $22,000 | +22.2% | 1,908 | +21.2% | 0.00% | – |
| Q4 2020 | $18,000 | +50.0% | 1,574 | 0.0% | 0.00% | – |
| Q3 2020 | $12,000 | -67.6% | 1,574 | -23.0% | 0.00% | – |
| Q2 2020 | $37,000 | +48.0% | 2,044 | +5.4% | 0.00% | – |
| Q1 2020 | $25,000 | +47.1% | 1,939 | +88.6% | 0.00% | – |
| Q4 2019 | $17,000 | +183.3% | 1,028 | +17.4% | 0.00% | – |
| Q3 2019 | $6,000 | – | 876 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 2,343,154 | $10,403,604 | 3.92% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,718,881 | $25,391,832 | 1.37% |
| COWEN AND COMPANY, LLC | 4,308,359 | $19,129,113 | 1.34% |
| RA Capital Management | 11,609,704 | $51,547,086 | 1.02% |
| RTW INVESTMENTS, LP | 5,818,804 | $25,835,490 | 0.54% |
| Acuitas Investments, LLC | 134,811 | $598,561 | 0.35% |
| Simplify Asset Management Inc. | 570,519 | $2,533,104 | 0.29% |
| Vivo Capital, LLC | 520,000 | $2,308,800 | 0.25% |
| BRANDYWINE MANAGERS, LLC | 26,127 | $116,004 | 0.20% |
| DENALI ADVISORS LLC | 70,600 | $313,464 | 0.11% |